How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Oil slides below US$100, stocks soar as Trump agrees to two-week ceasefire
Ringgit rebounds to 3.99 against US$ on improved sentiment
Bursa Malaysia rallies on ceasefire deal, analysts urge caution
Trading ideas: TM, U Mobile, AWC, Cahya Mata, DRB-Hicom, Joe, Meta Bright, Pharmaniaga, Sersol, Sinaran, Uzma, K Seng, Maxim, 5E, Empire, MTT, Aeon Credit
Sunway and IJM prospects remain bright
CBH Engineering sees expanding order book
Aeon Credit records higher FY26 net profit of RM386mil
MyNews growth intact
Meta Bright gets loan for EV charging plan
Central bank’s international reserves dip

Others Also Read